Vicarious Surgical (RBOT) Accumulated Expenses (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Accumulated Expenses came in at $501000.0 in Q4 2025, down 90.52% year-on-year from $5.3 million in Q4 2024, and down 44.64% on a QoQ basis from $905000.0 in Q3 2025.
Vicarious Surgical (RBOT) Accumulated Expenses (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Accumulated Expenses data on file, last reported at $501000.0 in Q4 2025.
- On a quarterly basis, Accumulated Expenses fell 90.52% year-over-year to $501000.0 in Q4 2025; TTM through Dec 2025 was $501000.0, a 90.52% decrease from a year earlier, with the FY2025 full-year figure at $501000.0, down 90.52% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $501000.0, down from $905000.0 in the prior quarter.
- Over the last five years, Accumulated Expenses for RBOT reached as high as $5.8 million in Q4 2022 and fell as low as $501000.0 in Q4 2025.
- Historically, Accumulated Expenses has averaged $3.5 million across 5 years, with a median of $3.9 million in 2022.
- Across the five-year window, Accumulated Expenses surged 1558.67% in 2021 and slumped 90.52% in 2025, its largest moves.
- Year by year, Accumulated Expenses stood at $4.1 million in 2021, then surged by 41.73% to $5.8 million in 2022, then declined by 14.34% to $5.0 million in 2023, then advanced by 6.19% to $5.3 million in 2024, then slumped by 90.52% to $501000.0 in 2025.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $501000.0 in Q4 2025, $905000.0 in Q3 2025, and $2.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 501,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 5.57 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 4.98 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 5.37 Mn |
| Jun 30, 2022 | 3.88 Mn |
| Mar 31, 2022 | 3.05 Mn |
| Dec 31, 2021 | 4.10 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 2.09 Mn |
| Mar 31, 2021 | 1.46 Mn |